aTyr Pharma, Inc.
Biotechnology
Healthcare
ATYR
75.80 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
2.68
52 week high
4.43
high
2.98
52 week low
1.46
low
2.53
growth
65.90 %
previous Close
2.72
P/E ratio
market cap
144 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-17.26 M
-5.84 %
eps
0.00 %
-0.93 %
eps surprise
-3.50 %
net profit margin
-1725900000.00 %
0.00 %
operating incoming
-18.14 M
-4.78 %
net change in cash
4.68 M
1.00 %
cash on hand
11.46 M
68.38 %
cost of revenue
0.00 %
top top